Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

First small-molecule agonists of orphan estrogen-related receptors synthesized

April 19, 2005

Target selection in Celera Genomics and Abbott collaboration

April 19, 2005

Intranasal Technology inlicenses Aegis' Intravail drug delivery technology

April 18, 2005

SCOLR Pharma adds three drug targets to CDT drug development program

April 18, 2005

Pieris and Syngenta to develop Anticalins

April 15, 2005

Priority review and new development agreement for Enhanze SC

April 11, 2005

Phase I/II study evaluates Inovio's DNA delivery technology in prostate cancer

April 8, 2005

Halozyme files an NDA for Enhanze SC

April 7, 2005

BioFocus in drug target agreement with Lilly

March 7, 2005

Preclinical activity of a novel nonpeptide selective vasopressin V1A receptor antagonist, YM-218

March 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026